Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q00604 (
X-linked
)
16,883
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Molecular genetics has transformed clinical concepts of
Duchenne muscular dystrophy (DMD)
in several different ways. (1) The disease can now be defined as a myopathy due to mutation at Xp21, a specific locus on the short arm of the X chromosome. (2) As a consequence of that discovery, any myopathy due to mutation at Xp21 should be a variant of
DMD
and should affect the same gene product. Moreover, any myopathy due to mutation at a location other than Xp21 should affect some other gene product. (3) For these reasons, DNA analysis is now needed for clinical diagnosis of muscle disease. (4) Xp21 myopathies may be mild or severe, may occur in females even though
X-linked
, and may be manifest only by high serum levels of creatine kinase. (5) Mental retardation is not consistently related to diseases that are encoded at Xp21. The association of mental retardation with
DMD
may be due to mutation in a separate gene near that for
DMD
. Concepts may soon be altered again as we learn about the affected gene product (dystrophin) and its role in these diseases.
...
PMID:Clinical concepts of Duchenne muscular dystrophy. The impact of molecular genetics. 328 82
Duchenne muscular dystrophy (DMD)
is a debilitating
X-linked
muscle disease. We have used sequence information from complementary DNA clones, derived from the gene that is deleted in
DMD
patients, to generate an antiserum that stains the surface membrane of intact human and mouse skeletal muscle, but not that of
DMD
patients and mdx mice. Here we identify the protein reacting with this antiserum as a single component of relative molecular mass 210,000 (Mr = 210K) that fractionates with a low-ionic strength extract of intact human and mouse skeletal muscle. It is therefore distinct from the 400 K protein found in the heavy microsomal fraction of normal muscle and identified as a putative product of the
DMD
gene. We also analyse further the disease specificity of the antiserum. Positive staining is seen in normal controls, and in samples from patients with a wide range of muscular dystrophies other than
DMD
. Becker muscular dystrophy, which is allelically related to
DMD
, was the only other exception, and gave a sporadic staining pattern. The demonstration of a specific defect in the surface membrane of
DMD
muscle fibres substantiates the hypothesis that membrane lesions may initiate muscle degradation in
DMD
.
...
PMID:Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. 329 Jun 83
Duchenne muscular dystrophy (DMD)
is the most common and the most severe of the muscular dystrophies in man. It is inherited as an X-linked recessive trait and is characterized by ongoing necrosis of skeletal muscle fibres with regeneration and eventually fibrosis and fatty infiltration. Although the gene and gene product which are defective in
DMD
have recently been identified, the pathogenesis of the disease is still poorly understood. A myopathy has been described in the dog which has been shown to be inherited as an
X-linked
trait and which is therefore a potential model of the human disease. We have studied the phenotypic expression of the disease, canine
X-linked muscular dystrophy
(CXMD), and have examined the molecular relationship between it and
DMD
. We report here that dogs with CXMD faithfully mimic the phenotype of
Duchenne muscular dystrophy
and that they lack the Duchenne gene transcript and its protein product, dystrophin.
...
PMID:The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. 329 Jun 91
The original Virginia family with
X-linked muscular dystrophy
with early contractures and cardiomyopathy (Emery-Dreifuss type) has been reinvestigated 25 years later. The findings confirm that a cardiomyopathy, presenting most often as atrioventricular block, is a significant feature of the disease, which is characterized by the triad of: 1) slowly progressive muscle wasting and weakness with a humero-peroneal distribution in the early stages; 2) early contractures of the elbows, Achilles tendons, and post-cervical muscles; and 3) a cardiomyopathy usually presenting as heart block (some female carriers may also develop heart block). Other reported families with
X-linked
Emery-Dreifuss muscular dystrophy as well as a rare autosomal variant are reviewed, and differentiation from scapulo-peroneal muscular dystrophy and the rigid spine syndrome is discussed.
...
PMID:X-linked muscular dystrophy with early contractures and cardiomyopathy (Emery-Dreifuss type). 331 95
In a patient suffering from
X-linked
chronic granulomatous disease (X-CGD)--a disorder of phagocytesuperoxide generation--and McLeod syndrome, characterized by the absence of the red cell Kell antigen, we identified a deletion of the entire X-CGD gene by means of DNA hybridization with a cDNA probe. Our findings suggest that the X-CGD and McLeod loci are physically close in the p21 region of the X chromosome proximal to the
Duchenne muscular dystrophy
locus.
...
PMID:Gene deletion in a patient with chronic granulomatous disease and McLeod syndrome: fine mapping of the Xk gene locus. 333 97
The McLeod phenotype is an
X-linked
, recessive disorder in which the red blood cells demonstrate acanthocytic morphology and weakened antigenicity in the Kell blood group system. The phenotype is associated with a reduction of in vivo red cell survival, but the permanent hemolytic state is usually compensated by erythropoietic hyperplasia. The McLeod phenotype is accompanied by either a subclinical myopathy and elevated creatine kinase (CK) or
X-linked
chronic granulomatous disease (CGD). Seven males with the McLeod red-blood-cell phenotype and associated myopathy but not CGD, one male with the McLeod phenotype associated with CGD, and two males known to possess large deletions of the
Duchenne muscular dystrophy (DMD)
locus were studied. DNA isolated from each patient was screened for the presence or absence of various cloned sequences located in the Xp21 region of the human X chromosome. Two of the seven males who have only the McLeod phenotype and are cousins exhibit deletions for four Xp21 cloned fragments but are not deleted for any portion of either the CGD or the
DMD
loci. Comparison of the cloned segments absent from these two McLeod cousins with those absent from the two
DMD
boys and the CGD/McLeod patient leads to the submapping of various cloned DNA segments within the Xp21 region. The results place the locus for the McLeod phenotype within a 500-kb interval distal from the CGD locus toward the
DMD
locus.
...
PMID:Localization of the McLeod locus (XK) within Xp21 by deletion analysis. 335 22
Serum creatine kinase (CK) and myoglobin (Mb) levels were measured in patients with different neuromuscular diseases, carriers of
X-linked
Duchenne-type muscular dystrophy and normal volunteers. The highest levels were found in
Duchenne dystrophy
and both values decreased in parallel with age. In patients suffering from limb-girdle dystrophy the increases in CK activity and Mb concentration were also pronounced. However, there were families with normal and others with elevated CK and Mb levels in facioscapulohumeral dystrophy. In neurogenic atrophies both CK and Mb levels generally increased only slightly. Serum Mb and CK levels have similar values as indicators of muscle damage in primary and secondary skeletal muscle disorders. The serum Mb level helps in the detection of carriers but is not more sensitive than CK measurement.
...
PMID:The significance of simultaneous estimation of serum creatine kinase and myoglobin in neuromuscular diseases. 336 67
The article describes two familial cases of
pseudohypertrophic progressive muscular dystrophy
with an onset in the pubertal age and a malignant course of the myodystrophic process. The cases presented are the first ever reported in the world literature. The questions of inter- and intrafamilial polymorphism of recessive
X-linked
forms of progressive muscular dystrophies are discussed.
...
PMID:[Pseudohypertrophic forms of progressive muscular dystrophy with the onset at puberty and a malignant course of the myodystrophic process]. 338 16
Classical segregation analysis was performed on 651 male probands in 597 families with
Duchenne muscular dystrophy (DMD)
collected from 20 of 25 National Institutions for Muscle Diseases in Japan. The proportion of sporadic cases is compatible with 1/3 expected for an
X-linked
lethal trait with an equal mutation rate in egg and sperm, the estimated mutation rates being 9.2 X 10(-5) and 10.9 X 10(-5)/gamete/generation, respectively. The incidence and prevalence among males were estimated to be 29.2 X 10(-5) and 6.7 X 10(-5), respectively. These results indicated no difference from the patterns of
DMD
in Western countries.
...
PMID:Genetic epidemiology of Duchenne muscular dystrophy in Japan: classical segregation analysis. 342 71
Haplotypes for 7 flanking and 16 "intragenic"
X-linked
DNA polymorphisms were determined in 204 members of 31 families with Duchenne (
DMD
) and 27 members of 4 families with Becker type muscular dystrophy (BMD) and combined with CK and pedigree data to estimate carrier and fetal risks. All of the 27 younger female relatives of the familial cases (8
DMD
, 2 BMD) could either be identified (11) or ruled out (16) as carriers with 95% or higher probability. Out of 49 possible carriers in the 23
DMD
and 2 BMD families with isolated cases, 19 were classified as carriers and 18 as homozygote-normal females. In 3 families the mutation could be traced indirectly to a defined ancestor (mother, grand-parent), and in 5 families a molecular deletion was found. In all identified carriers and in medium risk females an informative DNA-constellation for prenatal predictions was present for at least one "intragenic" or two flanking markers. Prenatal DNA-investigations were carried out during pregnancy in 9 possible
DMD
carriers. There was one termination due to an XYY karyotype. Of the remaining 8 cases, the carrier state could be ruled out in 4 mothers, the fetal sex was female in another 3, and one male fetus was predicted normal. All babies (3 boys, 5 girls) are healthy. The practical significance of these findings with regard to the prevention of
DMD
/BMD and the present diagnostic strategies are discussed.
...
PMID:[Carrier diagnosis and prenatal prognosis using DNA analysis in X-chromosome-linked Duchenne and Becker muscular dystrophy]. 343 90
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>